跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 372 条关于
“dihydropyrimidine dehydrogenase”
全部
372
临床试验
163
药物
47
机构
0
资讯
162
7个月前
FDA Mandates Genetic Testing for Xeloda and 5-FU to Prevent Fatal Toxicities in DPD-Deficient Patients
去年
Processa Pharmaceuticals Doses First Patient in Phase II Trial of NGC-Cap for Metastatic Breast Cancer
去年
Pharmacogenetic Testing Could Benefit Most Cancer Patients, UK Study Finds
11个月前
FDA Mandates DPYD Genetic Testing Before Capecitabine Chemotherapy to Prevent Fatal Toxicity
去年
NCCN Updates Guidelines to Recommend DPYD Testing Before Fluoropyrimidine Chemotherapy
2个月前
Saol Therapeutics Resubmits NDA for SL1009 (DCA) in Pyruvate Dehydrogenase Complex Deficiency Following FDA Alignment
去年
Foresee Pharmaceuticals Launches Phase 2 Trial of Mirivadelgat for Pulmonary Hypertension Associated with Interstitial Lung Disease
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
FDA Grants Priority Review to Saol Therapeutics' SL1009 for Rare Pediatric Mitochondrial Disorder
去年
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver for IDH-Mutant Gliomas in India
第 1 页，共 17 页
上一页
下一页
